Alethia Young - 01 Apr 2022 Form 4 Insider Report for Graphite Bio, Inc. (LENZ)

Role
Chief Financial Officer
Signature
/s/ Zed Zduniak, attorney-in-fact
Issuer symbol
LENZ
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
05 Apr 2022, 18:01:08 UTC
Next filing
10 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRPH Stock Option (right to buy) Award $0 +350,000 $0.000000 350,000 01 Apr 2022 Common Stock 350,000 $5.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to such option will vest and become exercisable on April 1, 2023 and 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.